Ait Therapeutics (AITB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AITB | GNTA | LTRN | ||
| Company | Ait Therapeutics | Genenta Science S.P.A. ADR | Lantern Pharma Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 4.7298 | 3.29 | 5.29 | ||
| High | 4.9700 | 3.30 | 5.60 | ||
| Low | 4.6500 | 3.29 | 5.29 | ||
| Last | 4.6500 | 3.29 | 5.60 | ||
| Change | -0.3200 | +0.21 | +0.50 | ||
| % Change | -6.44% | +6.66% | +9.80% | ||
| Volume | 3,400 | 2,127 | 68,196 | ||
| 20-Day Average Volume | N/A | 7,571 | 206,531 | ||
| Previous Close | 4.9700 | 3.08 | 5.10 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | N/A | 3.31 | 6.18 | ||
| 20-Day Raw Stochastic | N/A | 62.23% | 13.22% | ||
| 20-Day Relative Strength | N/A | 47.24% | 44.16% | ||
| Weighted Alpha | N/A | -48.52 | -42.19 | ||
| Today's Opinion | N/A | 100% Sell | 32% Buy | ||
| Previous Opinion | N/A | 100% Sell | 24% Buy | ||
| Last Month's Opinion | N/A | 100% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.44% since 01/10/20 | +29.41% since 04/24/24 | +0.74% since 04/24/24 | ||
| Low | 4.6500 on 01/17/20 | 2.49 on 04/26/24 | 4.89 on 04/29/24 | ||
| High | 4.9700 on 01/17/20 | 3.30 on 05/01/24 | 6.04 on 04/26/24 | ||
| 1-Month | |||||
| %Chg | N/A since 01/10/20 | -8.59% since 04/01/24 | -43.01% since 04/01/24 | ||
| Low | 4.6500 on 01/17/20 | 2.20 on 04/24/24 | 4.89 on 04/29/24 | ||
| High | 4.9700 on 01/17/20 | 3.97 on 04/22/24 | 9.35 on 04/02/24 | ||
| 3-Month | |||||
| %Chg | N/A since 01/10/20 | -16.74% since 02/01/24 | +28.13% since 02/01/24 | ||
| Low | 4.6500 on 01/17/20 | 2.20 on 04/24/24 | 3.85 on 02/23/24 | ||
| High | 4.9700 on 01/17/20 | 4.90 on 02/20/24 | 11.99 on 03/25/24 | ||
| 6-Month | |||||
| %Chg | N/A since 01/10/20 | -38.20% since 10/31/23 | +111.72% since 11/01/23 | ||
| Low | 4.6500 on 01/17/20 | 2.20 on 04/24/24 | 2.53 on 11/02/23 | ||
| High | 4.9700 on 01/17/20 | 5.50 on 11/20/23 | 11.99 on 03/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 55,444 | 56,108 | 54,779 | ||
| Shares Outstanding, K | 10,581 | 18,217 | 10,741 | ||
| Annual Sales | 7,720,000 | 0 | 0 | ||
| Annual Net Income | -6,560,000 | -12,600,000 | -15,960,000 | ||
| Last Quarter Sales | 7,700,000 | N/A | 0 | ||
| Last Quarter Net Income | -50,000 | N/A | -4,190,000 | ||
| 60-Month Beta | -0.26 | 0.72 | 1.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | -0.39 on 03/18/24 | ||
| Latest Earnings Date | 06/25/19 | 04/24/24 | 05/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||